Orphan medicines framework call-off awarded by Badalona Serveis Assistencials

Submission deadline
Not available
Award amount
€38,298.66
Contract period
1 year
Published
November 22, 2021

spain-placsp-aggregated

Overview

Badalona Serveis Assistencials awarded a one-year framework call-off for non-oncology orphan medicines. The Catalan public procurement API records three offers and names INTERCEPT PHARMA SPAIN, CHIESI ESPAÑA and ROCHE FARMA with separate amounts. It lists a 4% VAT rate and an award date distinct from the later contract formalization date. The published excluding-VAT award lines add up to one cent more than the tender budget; the API does not explain the difference.

Information based on the public notice

What the buyer needs

Supply of orphan medicines, excluding oncology medicines, through a call-off under a framework agreement.

  • The API identifies a negotiated procedure without publication and says the processing was ordinary.
  • Three offers were received.

Award details

Supplier
INTERCEPT PHARMA SPAIN, SL; CHIESI ESPAÑA, SAU; ROCHE FARMA, SA
Award date
November 17, 2021
Award amount
€38,298.66

Tender details

Buyer
Badalona Serveis Assistencials, SA
Country
Spain
Procedure
Negotiated without publication; ordinary processing
Classification
Orphan medicines · 33600000 — pharmaceutical products · NUTS ES51
Notice reference
8740985
File reference
CB BSA CSC F 2/21
Framework call-off
Orphan, non-oncology medicines under a framework agreement
Contract type
Supplies — acquisition
Tender budget excluding VAT
€38,298.65
Tender budget including VAT
€39,830.59; VAT 4%
Estimated contract value
€38,298.65
Contract duration
1 year
Offers received
3
Awardees and amounts excluding VAT
INTERCEPT PHARMA SPAIN, SL €2,173.97; CHIESI ESPAÑA, SAU €2,186.99; ROCHE FARMA, SA €33,937.70; published line amounts total €38,298.66
Awardee amounts including VAT
INTERCEPT PHARMA SPAIN, SL €2,260.93; CHIESI ESPAÑA, SAU €2,274.47; ROCHE FARMA, SA €35,295.20
Award date in API
17 November 2021 23:00 UTC (field labelled dataAdjudicacio)
Contract formalization date in API
21 November 2021 23:00 UTC (separate field)

What to check in the tender documents

  • The API lists an award-resolution PDF but it was not opened. It does not identify the medicine names, quantities, delivery schedule, or a lot number. The listed excluding-VAT award lines total €38,298.66, one cent above the stated excluding-VAT budget and estimated value (€38,298.65); the API gives no explanation.
Get started with Ziva

Original notice

Read the original description

Contracte basat de l'Acord marc del subministrament de Medicaments Orfes, no oncològics

Títol Contracte basat de l'Acord marc del subministrament de Medicaments Orfes, no oncològics Òrgan de contractació Badalona Serveis Assistencials, SA Codi d'expedient CB BSA CSC F 2/21 Sistema de racionalització Acord Marc Tramitació Ordinària Tipus de contracte Subministraments — Adquisició Procediment d'adjudicació Negociat sense publicitat Finançament MRR No Descripció de la prestació Contracte basat de l'Acord marc del subministrament de Medicaments Orfes, no oncològics Pressupost de licitació sense IVA 38.298,65 EUR Pressupost de licitació amb IVA 39.830,59 EUR IVA 4 % Durada 1 any Àmbit geogràfic Catalunya Valor estimat del contracte 38.298,65 EUR Contracte harmonitzat No Modificacions previstes No Data de publicació de la fase 22/11/2021 14:54 UTC (tal com consta a l'API) Lot No consta número de lot; lot desert: No Ofertes rebudes 3 Adjudicataris i imports sense IVA INTERCEPT PHARMA SPAIN, SL — 2.173,97 EUR CHIESI ESPAÑA, SAU — 2.186,99 EUR ROCHE FARMA, SA — 33.937,70 EUR Imports amb IVA INTERCEPT PHARMA SPAIN, SL — 2.260,93 EUR CHIESI ESPAÑA, SAU — 2.274,47 EUR ROCHE FARMA, SA — 35.295,20 EUR Data d'adjudicació indicada per l'API 17/11/2021 23:00 UTC Data de formalització indicada per l'API 21/11/2021 23:00 UTC Codi CPV 33600000 Documents enumerats a la fitxa Resolució d'adjudicació.pdf (no consultada)

Official source: spain-placsp-aggregated ↗